What Is Going On With Germany’s Cannabis Bid?

Germany is proceeding down the path to officially grow its own medical cannabis crops. Medical use became legal this year, along with a federal mandate for cheap access. That means that public health insurance companies, which cover 90% of Germans, are now firmly on the hook if not front line […]

What’s Happening on Capitol Hill? Part 3: The Medical Bills

This article continues the bill-by-bill review begun in the August 1st article of cannabis reform legislation proposed in the 115th Congress. In the next article and final piece in this series, we will examine the banking and tax reform bills related to cannabis. Medical Cannabis Reform Bills  1008 – Therapeutic […]

The Problem With Puerto Rico’s Medical Cannabis

Recently Puerto Rico approved the law that regulates the production, manufacturing, dispensing and consumption of medical cannabis. Although medical cannabis was already “legal” through an executive order and was “supervised” by local regulation, there was no law to back up the industry and protect investors. The creation and approval of […]

Is There a Medical Cannabis Crisis Brewing in Germany?

There is a great deal to be happy about with medical cannabis legalization in Germany. This is the first country that has mandated insurance coverage of the drug – at least at the federal legislative level. However, as the government evaluates the finalists in the first tender bid for domestically […]

What’s Happening on Capitol Hill? Part 2: A Bill-By-Bill Review

Since the first session of the 115th Congress convened on January 3, 2017, twenty-four cannabis reform bills have been introduced, fifteen in the House and nine in the Senate. All of them address in varying ways the puzzles that have emerged as more and more states legalize cannabis in the […]

Senate Committee Votes to Keep Medical Cannabis Protections

The Senate Appropriations Committee approved the amendment to continue protecting state-legal medical cannabis markets from the Department of Justice. The amendment, previously known as the Rohrabacher-Farr Amendment, prevents the DOJ from using funds to target medical cannabis operations, patients and businesses in states where it is legal. Every time Congress reviews […]

What’s Happening on Capitol Hill? Cannabis Reform Proposals and the 115th Congress

As CIJ readers are probably aware, last month Congress passed the Consolidated Appropriations Act of 2017—the annual budget, in other words. Lying within this 1,665-page document is Section 537, which for one year restricts the Department of Justice from using any funds to prevent states from implementing their medical cannabis […]

National Association of Cannabis Businesses Announces Launch

According to a press release, the National Association of Cannabis Businesses (NACB) launches today, becoming the first self-regulatory organization (SRO) for the cannabis industry. With their mission to help compliance, transparency and growth of cannabis companies, they will lead member businesses in establishing voluntary national standards, addressing issues like advertising […]

Former Mexican President Ridicules Justice Department’s Cannabis Policy

This week, the National Cannabis Industry Association (NCIA) hosted their annual Cannabis Business Summit in Oakland, California amid some alarming news in Washington. On Monday, a letter written by U.S. Attorney General Jeff Sessions back in early May made its way into the news, where he writes to Congress asking […]

What Does The Constitution Have To Say About Cannabis Legalization?

With the Trump Administration sending mixed signals on legal cannabis, and with Congress beginning to ramp up efforts for reform, in order for industry stakeholders to best understand where we are headed, it will be helpful to remember how we got here. As readers may be aware, the current status […]